Cargando…
Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
The current study evaluated retinal function using electroretinography (ERG) in cognitively healthy (CH) participants with preclinical Alzheimer’s disease (AD), as classified by cerebral spinal fluid (CSF) Aβ(42)/Tau ratio. Individuals with normal retinal morphology ascertained by spectral-domain op...
Autores principales: | Asanad, Samuel, Felix, Christian M., Fantini, Michele, Harrington, Michael G., Sadun, Alfredo A., Karanjia, Rustum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973731/ https://www.ncbi.nlm.nih.gov/pubmed/33737516 http://dx.doi.org/10.1038/s41598-021-85010-1 |
Ejemplares similares
-
Hormone replacement therapy in Leber's hereditary optic neuropathy: Accelerated visual recovery in vivo
por: Fantini, Michele, et al.
Publicado: (2018) -
Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer’s disease
por: Oh, Angela J., et al.
Publicado: (2019) -
Correction: Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer’s disease
por: Oh, Angela J., et al.
Publicado: (2020) -
The retinal choroid as an oculovascular biomarker for Alzheimer's dementia: A histopathological study in severe disease
por: Asanad, Samuel, et al.
Publicado: (2019) -
The Retina in Alzheimer's Disease: Histomorphometric Analysis of an Ophthalmologic Biomarker
por: Asanad, Samuel, et al.
Publicado: (2019)